Studies have shown that certain polymorphisms in the promoter region of the EPHX2 gene may affect the metabolism of lung cancer-related substances by regulating the activity of related enzymes, thereby participating in the occurrence and development of lung cancer. This evidence concerns the gene EPHX2 and lung carcinoma.